A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients.
Surg Open Sci
; 9: 51-57, 2022 Jul.
Article
in En
| MEDLINE
| ID: mdl-35663797
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Surg Open Sci
Year:
2022
Document type:
Article
Country of publication:
United States